1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-(imidazo[1,2-a]pyridin-6-yl)-1H-pyrazol-3-yl)urea

ID: ALA2207439

Chembl Id: CHEMBL2207439

PubChem CID: 71450691

Max Phase: Preclinical

Molecular Formula: C25H26N8O

Molecular Weight: 454.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(-c3ccc4nccn4c3)[nH]n2)cc1

Standard InChI:  InChI=1S/C25H26N8O/c1-16-5-8-18(9-6-16)33-23(14-20(31-33)25(2,3)4)28-24(34)27-21-13-19(29-30-21)17-7-10-22-26-11-12-32(22)15-17/h5-15H,1-4H3,(H3,27,28,29,30,34)

Standard InChI Key:  RNIUJCMMWSKQLR-UHFFFAOYSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTK2B Tclin Protein tyrosine kinase 2 beta (2827 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ptk2b Protein-tyrosine kinase 2-beta (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.54Molecular Weight (Monoisotopic): 454.2230AlogP: 5.16#Rotatable Bonds: 4
Polar Surface Area: 104.93Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.37CX Basic pKa: 6.27CX LogP: 4.99CX LogD: 4.96
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: -2.20

References

1. Bhattacharya SK, Aspnes GE, Bagley SW, Boehm M, Brosius AD, Buckbinder L, Chang JS, Dibrino J, Eng H, Frederick KS, Griffith DA, Griffor MC, Guimarães CR, Guzman-Perez A, Han S, Kalgutkar AS, Klug-McLeod J, Garcia-Irizarry C, Li J, Lippa B, Price DA, Southers JA, Walker DP, Wei L, Xiao J, Zawistoski MP, Zhao X..  (2012)  Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.,  22  (24): [PMID:23153798] [10.1016/j.bmcl.2012.10.039]

Source